Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1269

Oct 11, 2021

Biologist harnesses power of tiny worms in project that could reshape way cancer is screened and treated

Posted by in category: biotech/medical

Circa 2017


Call it worm power.

Continue reading “Biologist harnesses power of tiny worms in project that could reshape way cancer is screened and treated” »

Oct 11, 2021

The discovery of red blood cells acting as micro-electrodes opens new doors in medical research

Posted by in categories: biotech/medical, futurism

In a paper published in Scientific Reports, academics at the University of Surrey have discovered that biological cells generate an electric field voltage that appears outside and not just within, meaning each cell acts as a tiny electrode. Since this voltage impacts how cells interact with their environment, including the way cells stick to one another, this has significant potential implications for future medical treatments.

Since the 1790s, scientists have known that electricity plays a role in the function of life, with the discovery in the 1940s that every cell contains a that controls many of its functions. This is particularly the case in muscle and nerve cells but has also been shown to play an important role in diseases such as cancer.

However, until now, this voltage has always been understood to be contained within the cell. Through intricate experiments with , the Surrey-led research team has shown that the voltage appears outside the cell as well. This means that cells effectively act as tiny transmitters, electrically changing the environment around them. Similar results in other types of could play a significant role in determining new types of medical treatment.

Oct 11, 2021

How AI And A Strong Need For Sustainability Is Affecting The Travel Industry’s Evolution By Jason Fong

Posted by in categories: biotech/medical, robotics/AI, sustainability

2021 is only halfway complete, and we cannot yet be said to have defeated the pandemic, but yet at the same time, the travel and tourism industry is said to be poised for a pretty rapid boom. In many ways and places, the recovery has already begun.

A live Globaldata poll showed that people are desperate to enjoy travels and trips again with a majority of them opting for longer trips than before. 26% of their respondents showed a desire to enjoy trips that spanned a minimum of 10 nights. As lockdowns and travel restrictions continue to be eased and countries continue to open up, we will likely see a surge in new tourists and travelers.

Jason Fong, a veteran of the industry, is the brain behind the Boss of Bali brand, a brand that has garnered over 2 million followers on Instagram. Fong shared his knowledge of all things tourism and how he has used his platform to promote the evolution of travel and tourism more sustainably.

Oct 11, 2021

Himalayan fungus compound refined to offer 40 times the anti-cancer potency

Posted by in categories: biotech/medical, chemistry

By using a compound derived from a Himalayan fungus and used for centuries in Chinese medicine as a jumping off point, scientists have developed a new chemotherapy drug with powerful anti-cancer effects. Doing so involved chemically altering the compound to better infiltrate cancerous cells, which proved to boost its potency by up to 40 times.

Oct 11, 2021

Restoration of Visual Function and Cortical Connectivity After Ischemic Injury Through NeuroD1-Mediated Gene Therapy

Posted by in categories: biotech/medical, neuroscience

Neural circuits underlying brain functions are vulnerable to damage, including ischemic injury, leading to neuronal loss and gliosis. Recent technology of direct conversion of endogenous astrocytes into neurons in situ can simultaneously replenish the neuronal population and reverse the glial scar. However, whether these newly reprogrammed neurons undergo normal development, integrate into the existing neuronal circuit, and acquire functional properties specific for this circuit is not known. We investigated the effect of NeuroD1-mediated in vivo direct reprogramming on visual cortical circuit integration and functional recovery in a mouse model of ischemic injury. After performing electrophysiological extracellular recordings and two-photon calcium imaging of reprogrammed cells in vivo and mapping the synaptic connections formed onto these cells ex vivo, we discovered that NeuroD1 reprogrammed neurons were integrated into the cortical microcircuit and acquired direct visual responses. Furthermore, following visual experience, the reprogrammed neurons demonstrated maturation of orientation selectivity and functional connectivity. Our results show that NeuroD1-reprogrammed neurons can successfully develop and integrate into the visual cortical circuit leading to vision recovery after ischemic injury.

Functional circuit impairment associated with neuronal loss is commonly seen in patients with brain injuries, such as ischemia. Though neural stem cells (NSCs) exist in the subventricular zone (SVZ) in the adult brain, they are found to differentiate mainly into astrocytes when they migrate to injured cortex (Benner et al., 2013; Faiz et al., 2015), and their neurogenesis capacity is too limited to compensate for the neuronal loss. Currently, it still remains a challenge to generate neurons in adults and functionally incorporate them into the local circuits. Several strategies have shown the capability to induce neurogenesis and lead to some behavioral recovery. One promising approach is to transplant stem cell-derived neurons or neural progenitor cells (Tornero et al., 2013; Michelsen et al., 2015; Falkner et al., 2016; Somaa et al., 2017). Yet, there are concerns about graft rejection and tumorigenicity of the transplanted cells (Erdo et al., 2003; Marei et al., 2018).

Oct 10, 2021

A Paper Linking COVID-19 Vaccines to High Risk of Myocarditis Has Been Withdrawn

Posted by in category: biotech/medical

However, the numbers used by the study were wrong. The authors largely underestimated the amount of vaccines delivered, giving a number 25 times smaller than the actual amount.

They initially said that the number of vaccines delivered was 32,379 — when it was actually 854,930.

As a result of this miscalculation, the study was withdrawn on September 24 with the researchers saying in a statement: Our reported incidence appeared vastly inflated by an incorrectly small denominator (i.e. number of doses administered over the time period of the study).

Continue reading “A Paper Linking COVID-19 Vaccines to High Risk of Myocarditis Has Been Withdrawn” »

Oct 10, 2021

Emerging infectious disease caused by a tick-borne nairovirus identified in Japan

Posted by in category: biotech/medical

A previously unknown virus that can infect humans and cause disease has been identified by scientists in Japan. The novel infectious virus, named Yezo virus, is transmitted by tick bites and causes a disease characterized by fever and a reduction in blood platelets and leucocytes. The discovery was made by researchers at Hokkaido University and colleagues, and the results have been published in the journal Nature Communications.

Keita Matsuno, a virologist at Hokkaido University’s International Institute for Zoonosis Control, said: “At least seven people have been infected with this in Japan since 2,014 but, so far, no deaths have been confirmed.”

The Yezo virus was discovered after a 41-year-old man was admitted to the hospital in 2019 with fever and leg pain after being bitten by an arthropod believed to be a tick while he was walking in a local forest in Hokkaido. He was treated and discharged after two weeks, but tests showed he had not been infected with any known viruses carried by ticks in the region. A second patient showed up with similar symptoms after a tick bite the following year.

Oct 10, 2021

Researchers Suggest Gene-Based Therapy May Help Regenerate Teeth

Posted by in categories: biotech/medical, genetics

As adults live longer, demand for dental implants continues to grow. However, researchers at Kyoto University and the University of Fuki in Japan may be closer to finding a way to help adults continue to function with natural dentition.

According to the University of Fuki, scientists investigated the effects of monoclonal antibodies for USAG-1. Investigators focused on the USAG-1 gene that interacts with the two mechanisms responsible for tooth development — bone morphogenetic protein (BMP) and Wnt signaling. They found administering USAG-1-neutralizing antibodies affects BMP signaling only. The authors reports a single administration was enough to generate a whole tooth in mice and, in subsequent experiments, ferrets as well.

From Decisions in Dentistry. June 2021;7, 11.

Oct 10, 2021

Doctors implant lab-grown vagina

Posted by in category: biotech/medical

Circa 2014


Four women have had new vaginas grown in the laboratory and implanted by doctors in the US.

A tissue sample and a biodegradable scaffold were used to grow vaginas in the right size and shape for each woman as well as being a tissue match.

Continue reading “Doctors implant lab-grown vagina” »

Oct 10, 2021

How health care AI could help train tomorrow’s physicians

Posted by in categories: biotech/medical, health, robotics/AI

As the medical community’s understanding of the application of augmented intelligence (AI) in health care grows, there remains the question of how AI—often called artificial intelligence—should be incorporated into physician training. The term augmented intelligence is preferred because it recognizes the enhancement, rather than replacement, of human capabilities.

Understanding how AI can affect patients may help learners appreciate its relevance, he noted, adding that the National Board of Medical Examiners exam now tests physicians-in-training on health systems science, and there are questions about health care AI specifically.

But AI doesn’t just relate to systems issues. It also has a home within evidence-based medicine (EBM).

Continue reading “How health care AI could help train tomorrow’s physicians” »